$ERYP #Erytech Pharma SA Erytec Pharma : Major trigger at end-2020: interim data for phase III trial in pancreatic cancer: &gt;Company contact - Our recent contact with Eric Soyer, CFO of Erytech Pharma, provided an update on the company’s… https://t.co/5a944CWRdF #equity #stocks https://t.co/HVZO59OhJk